OXIS International, Inc. (OTCQB:OXIS) a biotech company that develops and commercializes innovative drugs of therapeutic molecules including cannabinoids, which are focused on several cancer indications. Today Oxis announced that it has received approval and is up-listing to the OTCQB. As an OTCQB listed company OXIS International, Inc. will be required to be current in their reporting and undergo an annual verification and management certification process, thus insuring a high level of compliance and transparency.